Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Analytical Biochemistry|November 23, 2006
Real-time PCR: duplexing without optimizationAndreas Edgar Hein, Ursula BodendorfJournal of Neurochemistry|April 16, 2002
The disulphide bonds in the catalytic domain of BACE are critical but not essential for amyloid precursor protein processing activityFrauke Fischer, Maurizio Molinari, Ursula Bodendorf, et al.Analytical Biochemistry|September 18, 2007
A sensitive fluorescence intensity assay for deubiquitinating proteases using ubiquitin-rhodamine110-glycine as substrateUlrich Hassiepen, Ulf Eidhoff, Gabriele Meder, et al.Journal of Neurochemistry|April 12, 2002
Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloidUrsula Bodendorf, Simone Danner, Frauke Fischer, et al.Plos One|November 12, 2021
Evaluation of protein kinase D auto-phosphorylation as biomarker for NLRP3 inflammasome activationDiane Heiser, Joëlle Rubert, Adeline Unterreiner, et al.Biotechnology and Bioengineering|May 20, 2018
Degradation of recombinant proteins by Chinese hamster ovary host cell proteases is prevented by matriptase-1 knockoutHolger Laux, Sandrine Romand, Sandro Nuciforo, et al.Proceedings of the National Academy of Sciences of the United States of America|December 14, 2011
A macrocyclic HCV NS3/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length targetNikolaus Schiering, Allan D'Arcy, Frederic Villard, et al.SLAS Discovery : Advancing Life Sciences R & D|July 22, 2017
Identification of SPPL2a Inhibitors by Multiparametric Analysis of a High-Content Ultra-High-Throughput ScreenXian Zhang, Marjo Götte, Yvonne Ibig-Rehm, et al.Biochemical and Biophysical Research Communications|February 9, 2021
Pharmacological inhibition of IKKβ dampens NLRP3 inflammasome activation after priming in the human myeloid cell line THP-1Adeline Unterreiner, Joëlle Rubert, Muriel Kauffmann, et al.Journal of Medicinal Chemistry|January 24, 2018
Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In VivoJuraj Velcicky, Ursula Bodendorf, Pascal Rigollier, et al.Pageof 2